MedPath
NMPA Approval

Sitagliptin Phosphate Tablets

国药准字H20244622

August 5, 2024

Drug Information

磷酸西格列汀片

片剂

50mg(按C₁₆H₁₅F₆N₅O计)

化学药品

August 5, 2024

Company Information

Applicant Company

江西省抚州市东乡区大富工业园区

Manufacturing Company

江西省抚州市东乡区大富工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸西格列汀片 - NMPA 批准文号 | MedPath